US equities
|
MU
$934.27
▲+0.00%
INTC
$92.07
▲+0.00%
SNDK
$1,330.05
▲+0.00%
AMZN
$243.79
▲+0.00%
NVDA
$213.66
▲+0.00%
AAPL
$348.91
▲+0.00%
GOOGL
$283.82
▲+0.00%
MSFT
$530.14
▲+0.00%
MU
$934.27
▲+0.00%
INTC
$92.07
▲+0.00%
SNDK
$1,330.05
▲+0.00%
AMZN
$243.79
▲+0.00%
NVDA
$213.66
▲+0.00%
AAPL
$348.91
▲+0.00%
GOOGL
$283.82
▲+0.00%
MSFT
$530.14
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about #covid/19
Recent news which mentions #covid/19
The Path to Job Mobility
February 11, 2022
Tickers
MA
Tags
Innovation & Technology
Brookings Institution
#InclusiveGrowth
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Merck and Ridgeback Announce Publication of Phase 3 Study of Molnupiravir, an Investigational Oral Antiviral COVID-19 Treatment, in the New England Journal of Medicine
December 17, 2021
Tickers
MRK
Tags
Innovation & Technology
Merck & Co
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News